Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 42

1.

Serotonin (5-HT) in veins: not all in vain.

Linder AE, Ni W, Diaz JL, Szasz T, Burnett R, Watts SW.

J Pharmacol Exp Ther. 2007 Nov;323(2):415-21. Review.

2.
3.

Serotonin transporter density and anxiolytic-like effects of antidepressants in mice.

Mirza NR, Nielsen EØ, Troelsen KB.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 May 9;31(4):858-66.

PMID:
17335951
4.

5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT).

Ni W, Watts SW.

Clin Exp Pharmacol Physiol. 2006 Jul;33(7):575-83. Review.

PMID:
16789923
5.

Using positron emission tomography to facilitate CNS drug development.

Lee CM, Farde L.

Trends Pharmacol Sci. 2006 Jun;27(6):310-6. Review.

PMID:
16678917
6.

A dose-finding study of duloxetine based on serotonin transporter occupancy.

Takano A, Suzuki K, Kosaka J, Ota M, Nozaki S, Ikoma Y, Tanada S, Suhara T.

Psychopharmacology (Berl). 2006 Apr;185(3):395-9.

PMID:
16506079
7.

Evaluation of carbon-11-labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-iodoethenyl)phenyl]nortropane as a potential radioligand for imaging the serotonin transporter by PET.

Plisson C, Jarkas N, McConathy J, Voll RJ, Votaw J, Williams L, Howell LL, Kilts CD, Goodman MM.

J Med Chem. 2006 Feb 9;49(3):942-6.

PMID:
16451060
9.

Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography.

Parsey RV, Kent JM, Oquendo MA, Richards MC, Pratap M, Cooper TB, Arango V, Mann JJ.

Biol Psychiatry. 2006 May 1;59(9):821-8.

PMID:
16213473
10.

Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?

Kish SJ, Furukawa Y, Chang LJ, Tong J, Ginovart N, Wilson A, Houle S, Meyer JH.

Nucl Med Biol. 2005 Feb;32(2):123-8.

PMID:
15721757
11.

Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors.

Kugaya A, Sanacora G, Staley JK, Malison RT, Bozkurt A, Khan S, Anand A, Van Dyck CH, Baldwin RM, Seibyl JP, Charney D, Innis RB.

Biol Psychiatry. 2004 Oct 1;56(7):497-502.

PMID:
15450785
12.

Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET.

Lu JQ, Ichise M, Liow JS, Ghose S, Vines D, Innis RB.

J Nucl Med. 2004 Sep;45(9):1555-9.

13.

Serotonin regulates osteoclast differentiation through its transporter.

Battaglino R, Fu J, Späte U, Ersoy U, Joe M, Sedaghat L, Stashenko P.

J Bone Miner Res. 2004 Sep;19(9):1420-31.

14.

The serotonin transporter is present and functional in peripheral arterial smooth muscle.

Ni W, Thompson JM, Northcott CA, Lookingland K, Watts SW.

J Cardiovasc Pharmacol. 2004 Jun;43(6):770-81.

PMID:
15167270
15.
16.

Serotonin transporter: a potential substrate in the biology of suicide.

Purselle DC, Nemeroff CB.

Neuropsychopharmacology. 2003 Apr;28(4):613-9. Review.

17.

Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.

Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB.

J Med Chem. 2003 Mar 13;46(6):925-35.

PMID:
12620070
18.

Plasma membrane monoamine transporters: structure, regulation and function.

Torres GE, Gainetdinov RR, Caron MG.

Nat Rev Neurosci. 2003 Jan;4(1):13-25. Review. No abstract available.

PMID:
12511858
19.
20.

Supplemental Content

Support Center